BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 19464287)

  • 1. Tormentic acid reduces vascular smooth muscle cell proliferation and survival.
    Fogo AS; Antonioli E; Calixto JB; Campos AH
    Eur J Pharmacol; 2009 Aug; 615(1-3):50-4. PubMed ID: 19464287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells.
    Matter CM; Rozenberg I; Jaschko A; Greutert H; Kurz DJ; Wnendt S; Kuttler B; Joch H; Grünenfelder J; Zünd G; Tanner FC; Lüscher TF
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):286-92. PubMed ID: 17204907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid inhibits proliferation of human coronary vascular cells (SI/MPL-ratio: 0.5): a novel candidate for systemic and local therapy of postinterventional restenosis.
    Voisard R; Krebs R; Baur R; Hombach V
    Coron Artery Dis; 2010 Aug; 21(5):286-91. PubMed ID: 20508518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of oestrogen receptor-expressing endothelial cells with oestrogen reduces proliferation of cocultured vascular smooth muscle cells.
    Odenlund M; Ekblad E; Nilsson BO
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):245-8. PubMed ID: 18290870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dehydroleucodine inhibits vascular smooth muscle cell proliferation in G2 phase.
    Cruzado M; Castro C; Fernandez D; Gomez L; Roque M; Giordano OE; Lopez LA
    Cell Mol Biol (Noisy-le-grand); 2005 Nov; 51(6):525-30. PubMed ID: 16309576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raphanus sativus and its isothiocyanates inhibit vascular smooth muscle cells proliferation and induce G(1) cell cycle arrest.
    Suh SJ; Moon SK; Kim CH
    Int Immunopharmacol; 2006 May; 6(5):854-61. PubMed ID: 16546717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of proliferation and apoptosis of vascular smooth muscle cells by ghrelin.
    Zhan M; Yuan F; Liu H; Chen H; Qiu X; Fang W
    Acta Biochim Biophys Sin (Shanghai); 2008 Sep; 40(9):769-76. PubMed ID: 18776988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressure alters endothelial effects upon vascular smooth muscle cells by decreasing smooth muscle cell proliferation and increasing smooth muscle cell apoptosis.
    Vouyouka AG; Jiang Y; Basson MD
    Surgery; 2004 Aug; 136(2):282-90. PubMed ID: 15300192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emodin induces growth arrest and death of human vascular smooth muscle cells through reactive oxygen species and p53.
    Wang X; Zou Y; Sun A; Xu D; Niu Y; Wang S; Wang K; Ge J
    J Cardiovasc Pharmacol; 2007 May; 49(5):253-60. PubMed ID: 17513942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel butyrolactone derivative inhibited smooth muscle cell migration and proliferation and maintained endothelial cell functions through selectively affecting Na, K-ATPase activity and mitochondria membrane potential during in vitro angiogenesis.
    Meng N; Zhao J; Zhao B; Cheng Y; Wang W; Zhang Y; Zhang S; Miao J
    J Cell Biochem; 2008 Aug; 104(6):2123-30. PubMed ID: 18393353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug delivery.
    Wessely R; Blaich B; Belaiba RS; Merl S; Görlach A; Kastrati A; Schömig A
    Thromb Haemost; 2007 Jun; 97(6):1003-12. PubMed ID: 17549304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation.
    Baskar R; Sparatore A; Del Soldato P; Moore PK
    Eur J Pharmacol; 2008 Oct; 594(1-3):1-8. PubMed ID: 18680741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tanshinone II A inhibits in vitro cellular proliferation and migration of vascular smooth muscle cell of rabbit].
    Zhang HH; Chen YC; Liang L; Zeng Z
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):188-92. PubMed ID: 18630680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11,13-dihydro-dehydroleucodine, a derivative of dehydroleucodine with an inactivated alkylating function conserves the anti-proliferative activity in G2 but does not cause cytotoxicity.
    Polo LM; Castro CM; Cruzado MC; Collino CJ; Cuello-Carrión FD; Ciocca DR; Giordano OS; Ferrari M; López LA
    Eur J Pharmacol; 2007 Feb; 556(1-3):19-26. PubMed ID: 17134695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of oxidated low-density lipoprotein on early apoptosis of vascular smooth muscle cell].
    Shen H; Yin M; Guo JH; Li TS; Luo Y; Yu LF
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 May; 15(5):295-8. PubMed ID: 12837191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF regulates FGF-2 and TGF-beta1 expression in injury endothelial cells and mediates smooth muscle cells proliferation and migration.
    Li D; Zhang C; Song F; Lubenec I; Tian Y; Song QH
    Microvasc Res; 2009 Mar; 77(2):134-42. PubMed ID: 18948122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide.
    Wang P; Xu TY; Guan YF; Su DF; Fan GR; Miao CY
    Cardiovasc Res; 2009 Feb; 81(2):370-80. PubMed ID: 18952695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
    Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR
    J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oxidized low density lipoprotein on the growth of human artery smooth muscle cells.
    Zhao GF; Seng JJ; Zhang H; She MP
    Chin Med J (Engl); 2005 Dec; 118(23):1973-8. PubMed ID: 16336833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-type natriuretic peptide for reduction of restenosis: gene transfer is superior over single peptide administration.
    Pelisek J; Fuchs AT; Kuehnl A; Tian W; Kuhlmann MT; Rolland PH; Mekkaoui C; Gaedtke L; Nikol S
    J Gene Med; 2006 Jul; 8(7):835-44. PubMed ID: 16602133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.